IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KVP Capital Advisors, LP

Q1 2026 Holdings

Filed 2026-05-13 | 32 holdings | $133.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Terns Pharmaceuticals Inc(TERN)COM880881107$23.2M440,00017.3%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$13.8M42,90010.3%
Whitehawk Therapeutics Inc(WHWK)COM00032Q104$7.5M2,165,9975.6%
Axsome Therapeutics Inc(AXSM)COM05464T104$6.1M36,2004.6%
Sutro Biopharma Inc(STRO)COM SHS869367201$5.6M226,5754.2%
Protagonist Therapeutics Inc(PTGX)COM74366E102$5.6M53,0004.2%
Erasca Inc(ERAS)COM29479A108$5.5M340,0004.1%
Trevi Therapeutics Inc(TRVI)COM89532M101$4.9M414,0003.7%
Tango Therapeutics Inc(TNGX)COM87583X109$4.8M230,2643.6%
Insmed Inc(INSM)COM PAR $.01457669307$4.7M28,4973.5%
Edgewise Therapeutics Inc(EWTX)COM28036F105$4.2M133,0003.1%
Revolution Medicines Inc(RVMD)COM76155X100$3.9M40,2002.9%
Disc Medicine Inc(IRON)COM254604101$3.7M58,2502.8%
MBX Biosciences Inc(MBX)COM55287L101$3.6M121,5242.7%
Savara Inc(SVRA)COM805111101$3.3M605,2802.5%
United Therapeutics Corp del(UTHR)COM91307C102$2.8M4,7502.1%
Travere Therapeutics Inc(TVTX)COM89422G107$2.7M91,0002.0%
Ideaya Biosciences Inc(IDYA)COM45166A102$2.7M79,7002.0%
Compass Therapeutics Inc(CMPX)COM20454B104$2.6M500,0002.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.5M300,0001.9%
Viridian Therapeutics Inc(VRDN)COM92790C104$2.4M125,0001.8%
Bright Minds Biosciences Inc(DRUG)COM NEW10919W405$2.3M31,8131.7%
Zura BIO LTD(ZURA)CLASS A ORD SHSG9TY5A101$2.2M373,1281.7%
Scholar Rock Hldg Corp(SRRK)COM80706P103$2.2M45,0001.7%
Immix Biopharma Inc(IMMX)COM45258H106$2.1M230,4231.6%
Soleno Therapeutics Inc(SLNO)COM834203309$2.0M59,7001.5%
Nektar Therapeutics(NKTR)COM NEW640268306$1.9M26,9001.4%
Cabaletta BIO Inc(CABA)COM12674W109$1.4M505,4311.0%
Achieve Life Sciences Inc(ACHV)COM004468500$1.4M462,3551.0%
Vera Therapeutics Inc(VERA)CL A92337R101$1.3M32,7001.0%
Celcuity Inc(CELC)COM15102K100$456.6K4,0000.3%
Vyne Therapeutics Inc(VYNE)COM92941V308$299.1K500,5510.2%